C4 Therapeutics, Inc. (CCCC) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for CCCC. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 144 institutions reported holding CCCC, with 117.6 million shares worth $547.6 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Morgan Stanley | 8,867,338 | $41M | DECREASED |
| RA Capital Management, | 8,000,000 | $37M | UNCHANGED |
| BlackRock | 7,896,718 | $37M | INCREASED |
| Lynx1 Capital Management | 7,326,691 | $34M | INCREASED |
| Squadron Capital Management | 7,200,000 | $34M | INCREASED |
Full institutional holdings, insider history, and congressional trades for C4 Therapeutics, Inc. on SentiSense.